Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Arcturus Therapeutics appoints Moncef Slaoui as chair designate
Arcturus Therapeutics (ARCT) announced the appointment of Moncef Slaoui as chair designate. Slaoui has been serving on the company’s board of ...
Arcturus Therapeutics names Moncef Slaoui as Chair Designate
Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as its Chair Designate. Dr. Slaoui, a notable figure ...
pharmaphorum5d
Ex-GSK chiefs Witty and Slaoui join biotech investors
Meanwhile his former colleague Moncef Slaoui, who also left GSK this year, has joined the European life science investor, Medicxi. Slaoui was formerly chairman of pharmaceutical R&D at GSK, and ...
Le Lézard3d
TE Connectivity named among World's Most Admired Companies by Fortune magazine for the eighth consecutive year
TE Connectivity , a world leader in connectors and sensors, has been named to Fortune's World's Most Admired Companies list ...
Le Lézard3d
CyberArk and SentinelOne Team Up to Enable Step Change in Endpoint and Identity Security
CyberArk , the identity security company, today announced a new integration with SentinelOne®'s AI-powered cybersecurity platform, SentinelOne Singularity, to protect against privileged access misuse.
OpenSecrets.org5d
COVID Lobbying: How former aides to Trump, congressional leaders lobbied their bosses amid the pandemic
OpenSecrets is 100% funded through the generosity of donors.